The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options ...
In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday ...
At least four analysts weighed in on the prospects for Europe’s second-largest company, Novo Nordisk, after the Danish ...
Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...
Neither drug is considered as effective as the brand-name weekly injections sold for diabetes and weight loss as Ozempic and Wegovy ... "prioritizes assessment of generic drug applications for ...
Those include Ozempic and its sister drug approved ... just without the brand name on the label. A generic drug, like the liraglutide generic approved Monday, is a copy of a brand-name drug ...